Get the Stockscreener App
2.50
1.96%
-0.05
After Hours:
2.42
-0.08
-3.20%
Shuttle Pharmaceuticals Holdings Inc stock is traded at $2.50, with a volume of 83,766.
It is down -1.96% in the last 24 hours and down -40.48% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$2.55
Open:
$2.48
24h Volume:
83,766
Relative Volume:
0.41
Market Cap:
$2.68M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-5.4348
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-15.82%
1M Performance:
-40.48%
6M Performance:
-61.24%
1Y Performance:
-91.45%
1-Day Range:
$2.2455
$2.5094
1-Week Range:
$2.2455
$3.56
52-Week Range:
$2.2455
$30.84
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
2.50 | 2.73M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
120.24 | 52.69B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.66 | 43.09B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.90B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
23.97 | 28.06B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.91 | 19.55B | 3.08B | 1.24B | 1.07B | 25.61 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
What risks investors should watch in Shuttle Pharmaceuticals Holdings Inc. stock2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
Best data tools to analyze Shuttle Pharmaceuticals Holdings Inc. stockIndex Update & Safe Entry Zone Tips - newser.com
How to manage a losing position in Shuttle Pharmaceuticals Holdings Inc.July 2025 Spike Watch & Stepwise Trade Signal Implementation - newser.com
Shuttle Pharmaceuticals Holdings Inc. stock trend outlook and recovery pathProduct Launch & Low Drawdown Momentum Trade Ideas - newser.com
Is Shuttle Pharmaceuticals Holdings Inc. a candidate for recovery playJuly 2025 Breakouts & Safe Capital Growth Tips - newser.com
Statistical indicators supporting Shuttle Pharmaceuticals Holdings Inc.’s strength2025 Price Momentum & Smart Money Movement Tracker - newser.com
Using data models to predict Shuttle Pharmaceuticals Holdings Inc. stock movementJuly 2025 Short Interest & Breakout Confirmation Trade Signals - newser.com
Analyzing recovery setups for Shuttle Pharmaceuticals Holdings Inc. investorsTrade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
What drives Shuttle Pharmaceuticals Holdings Inc stock priceMarket Profile Overview & Free Tremendous Return On Equity - earlytimes.in
Shuttle Pharmaceuticals Raises $2.5 Million in Private Placement - TipRanks
Will Shuttle Pharmaceuticals Holdings Inc. stock return to pre crisis levels2025 Fundamental Recap & Precise Trade Entry Recommendations - newser.com
Is Shuttle Pharmaceuticals Holdings Inc. meeting your algorithmic filter criteriaIndex Update & Free Technical Confirmation Trade Alerts - newser.com
How to integrate Shuttle Pharmaceuticals Holdings Inc. into portfolio analysis toolsWeekly Risk Report & Entry and Exit Point Strategies - newser.com
What technical charts say about Shuttle Pharmaceuticals Holdings Inc. stockMarket Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver surprise earnings beatChart Signals & Community Trade Idea Sharing Platform - newser.com
Will Shuttle Pharmaceuticals Holdings Inc. stock deliver shareholder valueWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Why Shuttle Pharmaceuticals Holdings Inc. stock is favored by top institutionsJuly 2025 Trade Ideas & AI Enhanced Trading Alerts - Fundação Cultural do Pará
Earnings visualization tools for Shuttle Pharmaceuticals Holdings Inc.Earnings Summary Report & Daily Oversold Stock Bounce Ideas - newser.com
Shuttle Pharmaceuticals Holdings Inc. stock retracement – recovery analysisOptions Play & Precise Trade Entry Recommendations - newser.com
Does Shuttle Pharmaceuticals Holdings Inc. show high probability of reboundTrade Exit Summary & Verified Entry Point Signals - newser.com
Is Shuttle Pharmaceuticals Holdings Inc. stock near bottom after declineJuly 2025 Movers & Fast Entry Momentum Trade Alerts - Fundação Cultural do Pará
Risk adjusted return profile for Shuttle Pharmaceuticals Holdings Inc. analyzedInflation Watch & Real-Time Price Movement Reports - newser.com
Is Shuttle Pharmaceuticals Holdings Inc. stock a top momentum play2025 Bull vs Bear & Weekly High Potential Alerts - Fundação Cultural do Pará
Is Shuttle Pharmaceuticals Holdings Inc. stock recession proofTrade Exit Summary & Real-Time Volume Analysis - Fundação Cultural do Pará
How Shuttle Pharmaceuticals Holdings Inc. stock reacts to inflationary pressuresDividend Hike & Consistent Income Trade Ideas - newser.com
Full technical analysis of Shuttle Pharmaceuticals Holdings Inc. stockWeekly Stock Recap & Precise Entry and Exit Recommendations - newser.com
Get in on Shuttle Pharmaceuticals Holdings Inc’s (SHPH) buy-in window today! - setenews.com
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):